Hydroxycarbamide for very young children with sickle cell anaemia

No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)37-38
Number of pages2
JournalEvidence-Based Medicine
Volume17
Issue number2
DOIs
StatePublished - Apr 2012

Fingerprint

Sickle Cell Anemia
Spleen
Kidney
Pain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{81c32d86b4a748ccba204fa9a537917b,
title = "Hydroxycarbamide for very young children with sickle cell anaemia: No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity",
author = "Manwani, {Deepa G.}",
year = "2012",
month = "4",
doi = "10.1136/ebm.2011.100104",
language = "English (US)",
volume = "17",
pages = "37--38",
journal = "Evidence-Based Medicine",
issn = "1356-5524",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Hydroxycarbamide for very young children with sickle cell anaemia

T2 - No effect on the primary outcomes of spleen or kidney function, but evidence for decreased pain and dactylitis, with minimal toxicity

AU - Manwani, Deepa G.

PY - 2012/4

Y1 - 2012/4

UR - http://www.scopus.com/inward/record.url?scp=84859445313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859445313&partnerID=8YFLogxK

U2 - 10.1136/ebm.2011.100104

DO - 10.1136/ebm.2011.100104

M3 - Article

VL - 17

SP - 37

EP - 38

JO - Evidence-Based Medicine

JF - Evidence-Based Medicine

SN - 1356-5524

IS - 2

ER -